Changmao Biochemical: July 2026 Monthly Return Shows Stable Share Capital and Full Public Float Compliance

Bulletin Express
08/03

Changmao Biochemical Engineering Company Limited reported no changes in either authorised or issued share capital for the month ended 31 July 2026, according to its latest submission to Hong Kong Exchanges and Clearing Limited dated 03 August 2026.

The company’s authorised share capital remained at RMB 52.97 million, comprising: • 183.70 million H shares, par value RMB 0.1 each. • 2.50 million domestic shares, par value RMB 0.1 each. • 343.50 million foreign shares, par value RMB 0.1 each.

Issued share capital was also unchanged, standing at 529.70 million ordinary shares, split as follows: • 183.70 million H shares listed on the Stock Exchange. • 2.50 million unlisted domestic shares. • 343.50 million unlisted foreign shares.

No treasury shares were held or cancelled, and no new share options, warrants, convertible securities, or other equity-linked instruments were issued during the period.

Management confirmed that the company met the Exchange’s minimum 25% public-float requirement for its H-share class as at 31 July 2026.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10